[1] |
Shrivastava AN, Triller A, Melki R. Cell biology and dynamics of neuronal Na +/K +-ATPase in health and diseases [J]. Neuropharmacology, 2020, 169: 107461. DOI: 10.1016/j.neuropharm.2018.12.008.
|
[2] |
Richards S, Aziz N, Bale S, et al. Standards and guidelines for the interpretation of sequence variants: a joint consensus recommendation of the American College of Medical Genetics and Genomics and the Association for Molecular Pathology[J]. Genet Med, 2015, 17(5): 405-424. DOI: 10.1038/gim.2015.30.
|
[3] |
Immanneni C, Calame D, Jiao S, et al. ATP1A3 disease spectrum includes paroxysmal weakness and encephalopathy not triggered by fever[J]. Neurol Genet, 2024, 10(3): e200150. DOI: 10.1212/NXG.0000000000200150.
|
[4] |
Calame DG, Moreno VC, Berger S, et al. Cation leak through the ATP1A3 pump causes spasticity and intellectual disability[J]. Brain, 2023, 146(8): 3162-3171. DOI: 10.1093/brain/awad124.
|
[5] |
Alyamani SA, Aldhalaan HM, Almuhaizea MA, et al. Expanding the allelic spectrum in ATP1A3-related disorders with 3 novel mutations and clinic features[J]. Neurosciences, 2023, 28(3): 195-198. DOI: 10.17712/nsj.2023.3.20220131.
|
[6] |
Williams L, Waller SE, Bradley M, et al. ATP1A3 related disease manifesting as rapid onset dystonia-parkinsonism with prominent myoclonus and exaggerated startle. Parkinsonism Relat Disord[J]. 2023, 117: 105864. DOI: 10.1016/j.parkreldis.2023.105864.
|
[7] |
Parfyonov M, Ivaniuk A, Parikh S, et al. Epilepsy with eyelid myoclonia in the setting of de novo pathogenic variant in ATP1A3[J]. Epileptic Disord, 2023, 25(4): 545-548. DOI: 10.1002/epd2.20086.
|
[8] |
Moriyama K, Mizuno T, Suzuki T, et al. ATP1A3-related early childhood onset developmental and epileptic encephalopathy responding to corpus callosotomy: a case report[J]. Brain Dev, 2023, 45(1): 77-81. DOI: 10.1016/j.braindev.2022.08.009.
|
[9] |
Martin AJ, Ong TL, Briceno MH, et al. ATP1A3-related relapsing encephalopathy with cerebellar ataxia (RECA): a genetic disorder with an inflammatory basis[J]. Mov Disord Clin Pract, 2022, 9(8): 1120-1123. DOI: 10.1002/mdc3.13564.
|
[10] |
Huang D, Song X, Ma J, et al. ATP1A3-related phenotypes in Chinese children: AHC, CAPOS, and RECA[J]. Eur J Pediatr, 2023, 182(2): 825-836. DOI: 10.1007/s00431-022-04744-w.
|
[11] |
Lacombe D, Van-Gils J, Lebrun M, et al. Hemidystonia with polymicrogyria is part of ATP1A3-related disorders[J]. Brain Dev, 2022, 44(8): 567-570. DOI: 10.1016/j.braindev.2022.05.001.
|
[12] |
Tahir S, Chencheri N, Abdalla AA, et al. A rare cause of recurrent febrile encephalopathy in a child: the expanding spectrum of ATP1A3 mutations[J]. Cureus, 2021, 13(12): e20438. DOI: 10.7759/cureus.20438.
|
[13] |
De Vrieze J, van de Laar IMBH, de Rijk-van Andel JF, et al. expanding phenotype of ATP1A3-related disorders: a case series[J]. Child Neurol Open, 2021, 8: 2329048X211048068. DOI: 10.1177/2329048X211048068.
|
[14] |
Prasuhn J, Göttlich M, Grosser SS, et al. In vivo brain sodium disequilibrium in ATP1A3-related rapid-onset dystonia-parkinsonism[J]. Mov Disord, 2022, 37(4): 877-879. DOI: 10.1002/mds.28954.
|
[15] |
Lax DN, Bieri P, Patel P. The diagnostic spectrum of ATP1A3-related disorders: 3 new patients[J]. Neurol Sci, 2021, 430: 120003. DOI: 10.1016/j.jns.2021.120003.
|
[16] |
Nomura S, Kashiwagi M, Tanabe T, et al. Rapid-onset dystonia-parkinsonism with ATP1A3 mutation and left lower limb paroxysmal dystonia[J]. Brain Dev, 2021, 43(4): 566-570. DOI: 10.1016/j.braindev.2020.12.009.
|
[17] |
Prange L, Pratt M, Herman K, et al. D-DEM, a distinct phenotype caused by ATP1A3 mutations[J]. Neurol Genet, 2020, 6(5): e466. DOI: 10.1212/NXG.0000000000000466.
|
[18] |
Shin C, Yoo D, Kim HJ, et al. Alternating hemiplegia of childhood in Korea: a case report[J]. Korean Med Sci, 2020, 35(26): e203. DOI: 10.3346/jkms.2020.35.e203.
|
[19] |
Sharawat IK, Kasinathan A, Suthar R, et al. CAPOS syndrome: a rare ATP1A3-related disorder[J]. Ann Indian Acad Neurol, 2020, 23(3): 397-398. DOI: 10.4103/aian.AIAN_41_19.
|
[20] |
Kim WJ, Shim YK, Choi SA, et al. Clinical and genetic spectrum of ATP1A3-related disorders in a Korean pediatric population[J]. Clin Neurol, 2020, 16(1): 75-82. DOI: 10.3988/jcn.2020.16.1.75.
|
[21] |
Balint B, Stephen CD, Udani V, et al. Paroxysmal asymmetric dystonic arm posturing-a less recognized but characteristic manifestation of ATP1A3-related disease[J]. Mov Disord Clin Pract, 2019, 6(4): 312-315. DOI: 10.1002/mdc3.12747.
|
[22] |
Nakamura Y, Hattori A, Nakashima M, et al. A de novo p.Arg756Cys mutation in ATP1A3 causes a distinct phenotype with prolonged weakness and encephalopathy triggered by fever[J]. Brain Dev, 2018, 40(3): 222-225. DOI: 10.1016/j.braindev.2017.09.010.
|
[23] |
Termsarasab P, Yang AC, Frucht SJ. et al. Phenotypes of ATP1A3 mutations: phenotype-genotype correlations[J]. Tremor Other Hyperkinet Mov (NY), 2015, 5: 336. DOI: 10.7916/D8MG7NS8.
|
[24] |
Dard R, Mignot C, Durr A, et al. Relapsing encephalopathy with cerebellar ataxia related to an ATP1A3 mutation[J]. Dev Med Child Neurol, 2015, 57(12): 1183-1186. DOI: 10.1111/dmcn.12927.
|
[25] |
Paciorkowski AR, McDaniel SS, Jansen LA, et al. Novel mutations in ATP1A3 associated with catastrophic early life epilepsy, episodic prolonged apnea, and postnatal microcephaly[J]. Epilepsia, 2015, 56(3): 422-30. DOI: 10.1111/epi.12914.
|
[26] |
Rosewich H, Baethmann M, Ohlenbusch A, et al. A novel ATP1A3 mutation with unique clinical presentation[J]. Neurol Sci, 2014, 341(1-2): 133-135. DOI: 10.1016/j.jns.2014.03.034.
|
[27] |
Travaglini L, Sabatini S, Garavaglia B, et al. Childhood-onset ATP1A3-related conditions: Report of two new cases of phenotypic spectrum[J]. Parkinsonism Relat Disord, 2016, 30: 81-82. DOI: 10.1016/j.parkreldis.2016.05.029.
|
[28] |
Hashimoto A, Kuki I, Fukuoka M, et al. Chronological dynamic changes in cortico-subcortical imbalance of cerebral blood flow in a boy with CAPOS syndrome[J]. Brain Dev, 2019, 41(7): 625-629. DOI: 10.1016/j.braindev.2019.03.003.
|
[29] |
Schirinzi T, Graziola F, Nicita F, et al. Childhood rapid-onset ataxia: expanding the phenotypic spectrum of ATP1A3 mutations[J]. Cerebellum, 2018, 17(4): 489-493. DOI: 10.1007/s12311-018-0920-y.
|
[30] |
Marrodan M, Rossi M, Merello M. Rapid-onset dystonia-parkinsonism preceded by a single episode of subacute persisting hemiparesis: expanding the ATP1A3-related disorders phenotype[J]. Neurol Sci, 2018, 392: 44-45. DOI: 10.1016/j.jns.2018.07.002.
|
[31] |
Stagnaro M, Pisciotta L, Gherzi M, et al. ATP1A3 spectrum disorders: a video-documented history of 7 genetically confirmed early onset cases[J]. Eur J Paediatr Neurol, 2018, 22(2): 264-271. DOI: 10.1016/j.ejpn.2018.01.010.
|
[32] |
|
[33] |
|
[34] |
|
[35] |
|
[36] |
杨广娥,赵忠礼,杨阳,等. ATP1A3基因突变致儿童交替性偏瘫:2例病例报道[J]. 中华医学科学杂志, 2021, 36(02):150-157. DOI: 10.24920/003850.
|
[37] |
|
[38] |
|
[39] |
|
[40] |
|
[41] |
|
[42] |
De Carvalho AP, Sweadner KJ, Penniston JT,et al. Mutations in the Na +/K + -ATPase alpha3 gene ATP1A3 are associated with rapid-onset dystonia parkinsonism [J]. Neuron, 2004, 43(2):169-175. DOI: 10.1016/j.neuron.2004.06.028.
|
[43] |
Heinzen EL, Swoboda KJ, Hitomi Y,et al. De novo mutations in ATP1A3 cause alternating hemiplegia of childhood [J]. Nat Genet, 2012, 44(9):1030-1034. DOI: 10.1038/ng.2358.
|
[44] |
Vezyroglou A, Akilapa R, Barwick K,et al. The phenotypic continuum of ATP1A3-related disorders [J]. Neurology, 2022, 99(14): e1511-e1526. DOI: 10.1212/WNL.0000000000200927.
|
[45] |
Li Y, Liu X, Wang C,et al. Molecular and clinical characteristics of ATP1A3-related diseases [J]. Front Neurol, 2022, 13:924788. DOI: 10.3389/fneur.2022.924788.
|
[46] |
|
[47] |
Lee M, Lui A, Chan J, et al. Revealing parental mosaicism: the hidden answer to the recurrence of apparent de novo variants [J]. Hum Genomics, 2023, 17(1): 91. DOI: 10.1186/s40246-023-00535-y.
|
[48] |
Cao Y, Tokita MJ, Chen ES, et al. A clinical survey of mosaic single nucleotide variants in disease-causing genes detected by exome sequencing [J]. Genome Med, 2019, 11(1): 48. DOI: 10.1186/s13073-019-0658-2.
|
[49] |
Shu L, Zhang Q, Tian Q,et al. Parental mosaicism in de novo neurodevelopmental diseases [J]. Am J Med Genet A, 2021, 185(7): 2119–2125. DOI: 10.1002/ajmg.a.62174.
|
[50] |
|